[go: up one dir, main page]

HK1119086A1 - Dipeptidyl peptidase inhibitors for treating diabetes - Google Patents

Dipeptidyl peptidase inhibitors for treating diabetes Download PDF

Info

Publication number
HK1119086A1
HK1119086A1 HK08113164.5A HK08113164A HK1119086A1 HK 1119086 A1 HK1119086 A1 HK 1119086A1 HK 08113164 A HK08113164 A HK 08113164A HK 1119086 A1 HK1119086 A1 HK 1119086A1
Authority
HK
Hong Kong
Prior art keywords
compound
pharmaceutical composition
composition according
single dose
dose form
Prior art date
Application number
HK08113164.5A
Other languages
German (de)
English (en)
French (fr)
Chinese (zh)
Other versions
HK1119086B (en
Inventor
Ronald J. Christopher
Paul Covington
Original Assignee
Takeda Pharmaceutical Company Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37564046&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1119086(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Takeda Pharmaceutical Company Limited filed Critical Takeda Pharmaceutical Company Limited
Publication of HK1119086A1 publication Critical patent/HK1119086A1/en
Publication of HK1119086B publication Critical patent/HK1119086B/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/513Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • A61K31/4261,3-Thiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/26Glucagons
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • A61K9/2018Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/48Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Hematology (AREA)
  • Biophysics (AREA)
  • Obesity (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • AIDS & HIV (AREA)
  • Emergency Medicine (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
HK08113164.5A 2005-09-14 2006-09-13 Dipeptidyl peptidase inhibitors for treating diabetes HK1119086B (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US71756005P 2005-09-14 2005-09-14
US60/717,560 2005-09-14
US74728006P 2006-05-15 2006-05-15
US60/747,280 2006-05-15
PCT/US2006/035958 WO2007033350A1 (en) 2005-09-14 2006-09-13 Dipeptidyl peptidase inhibitors for treating diabetes

Publications (2)

Publication Number Publication Date
HK1119086A1 true HK1119086A1 (en) 2009-02-27
HK1119086B HK1119086B (en) 2012-02-17

Family

ID=

Also Published As

Publication number Publication date
GEP20135838B (en) 2013-06-10
EA015169B1 (ru) 2011-06-30
CN101374523B (zh) 2012-04-11
ZA200901814B (en) 2010-06-30
HRP20120004T1 (en) 2012-03-31
HRP20120004T4 (hr) 2014-06-06
US20070060530A1 (en) 2007-03-15
EP1942898A1 (en) 2008-07-16
KR101345316B1 (ko) 2013-12-27
SI1942898T1 (sl) 2012-03-30
CA2622472A1 (en) 2007-03-22
CY1112281T1 (el) 2015-12-09
US8906901B2 (en) 2014-12-09
CR9874A (es) 2008-08-01
JP2009507930A (ja) 2009-02-26
RS52110B2 (sr) 2018-05-31
NO340910B1 (no) 2017-07-10
JP5027137B2 (ja) 2012-09-19
KR20080055875A (ko) 2008-06-19
EP1942898B2 (en) 2014-05-14
ZA200802857B (en) 2009-09-30
TW200744602A (en) 2007-12-16
CA2622472C (en) 2013-11-19
NZ566799A (en) 2011-04-29
ES2376351T3 (es) 2012-03-13
CN101374523A (zh) 2009-02-25
IL190131A (en) 2013-08-29
EP1942898B1 (en) 2011-11-09
MA29795B1 (fr) 2008-09-01
RS52110B (en) 2012-08-31
DK1942898T3 (da) 2012-01-09
AR055435A1 (es) 2007-08-22
ES2376351T5 (es) 2014-07-15
WO2007033350A1 (en) 2007-03-22
SI1942898T2 (sl) 2014-08-29
PL1942898T5 (pl) 2014-10-31
ME02005B (me) 2012-08-31
PL1942898T3 (pl) 2012-04-30
AU2006290205A1 (en) 2007-03-22
US20130172377A1 (en) 2013-07-04
EA200800726A1 (ru) 2008-08-29
ME01960B (me) 2015-05-20
TWI432200B (zh) 2014-04-01
MY147393A (en) 2012-11-30
DK1942898T4 (da) 2014-06-02
AU2006290205B2 (en) 2012-12-13
ATE532518T1 (de) 2011-11-15
IL190131A0 (en) 2008-11-03
US20110192748A1 (en) 2011-08-11
PE20070522A1 (es) 2007-07-11
PT1942898E (pt) 2011-12-20
BRPI0616055A2 (pt) 2011-06-07
NO20081592L (no) 2008-05-23

Similar Documents

Publication Publication Date Title
EP1942898B1 (en) Dipeptidyl peptidase inhibitors for treating diabetes
EP2073810B1 (en) Use of 2-6-(3-amino-piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydro-2h-pyrimidin-1-ylmethyl-4-fluoro-benzonitrile for treating diabetes, cancer, autoimmune disorders and hiv infection
US20190314352A1 (en) Administration of dipeptidyl peptidase inhibitors
EP2134348B1 (en) Weekly administration of dipeptidyl peptidase inhibitors
US20070060529A1 (en) Administration of dipeptidyl peptidase inhibitors
HK1119086B (en) Dipeptidyl peptidase inhibitors for treating diabetes
HK1131057B (en) Use of 2-6-(3-amino-piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydro-2h-pyrimidin-1-ylmethyl-4-fluoro-benzonitrile for treating diabetes, cancer, autoimmune disorders and hiv infection